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Candida albicans is a well-tolerated resident of hu-
man mucosal tissues. This implies that host defense
mechanisms cooperate to limit inflammation while
controlling fungal burden. The cytokine IL-22 and
inflammasomes are essential components of the
mucosal responses to C. albicans. How these com-
ponents cooperate to mediate the balance of inflam-
mation and host defense is not explored.We find that
NLRP3 inflammasome activation promotes neutro-
phil recruitment and inflammation during infection
and that this activity is counteracted by IL-22. Mech-
anistically, IL-22 activated NLRC4 for sustained
production of the IL-1 receptor antagonist IL-1Ra,
which restrained NLRP3 activity. Symptomatic infec-
tion in mice and humans occurred under conditions
of IL-1Ra deficiency and was rescued in mice by
replacement therapy with the recombinant IL-1Ra
anakinra. Thus, pathogenic inflammasome activity
during Candida infection is negatively regulated
by the IL-22/NLRC4/IL-1Ra axis. Our findings offer
insights into the pathogenesis of C. albicans and
suggest therapeutic avenues for candidiasis.
INTRODUCTION
The ability to tolerate Candida albicans, a human commensal of
the gastrointestinal tract and vagina, implies that host defense
mechanisms of resistance and tolerance cooperate to limit
fungal burden and inflammation at the different body sites. In
the vagina, Candida species are the causative agents of vulvo-
vaginal candidiasis (VVC) and recurrent VVC (RVVC), two forms
of disease that affect a large number of otherwise healthy
women. Uncomplicated VVC is associated with several predis-
posing factors, whereas RVVC, marked by idiopathic recurrent
episodes, represent a major therapeutic challenge. Whether a198 Cell Host & Microbe 18, 198–209, August 12, 2015 ª2015 Elsevidefective or exaggerated immune response toward Candida
spp. is responsible for the symptoms in VVC is still being
debated, but considerable evidence points to the association
of recurrent episodes of symptomatic infection with immune hy-
perreactivity to the fungus (Fidel, 2007; Piccinni et al., 2002;
Yano et al., 2012). An exaggerated and ineffective inflammation,
revealed by a robust vaginal polymorphonuclear neutrophil
(PMN) migration, occurs in susceptible women, promoting path-
ological inflammation without affecting fungal burden (Fidel,
2005; Peters et al., 2014b). As PMN depletion protected mice
from VVC (Peters et al., 2014a), regulation of PMN recruitment
and activity may need to be tightly controlled to prevent the
state of nonresolving inflammation occurring during symptom-
atic infection.
By promoting PMN recruitment, IL-1 signaling essentially me-
diates local and systemic inflammation (Garlanda et al., 2013).
However, evidence also revealed the pathologic role of IL-1-
mediated inflammation in a broad spectrum of human diseases,
and pharmacological blockade of IL-1 activity in inflammatory
diseases is beneficial (Dinarello et al., 2012; Dinarello and van
der Meer, 2013). IL-1b, IL-1a, and IL-18 contribute to host anti-
fungal immune resistance (Bellocchio et al., 2004; Mencacci
et al., 2000; Vonk et al., 2006), and the inflammasome, a multi-
protein complex whose formation results in activation of the
cysteine protease caspase-1, is responsible for the activation
of these cytokines from their inactive precursors (Joly and Sut-
terwala, 2010). The transition from the yeast to the filamentous
form of the fungus is sufficient (Gross et al., 2009; Hise et al.,
2009; Joly et al., 2009), although not essential (Wellington
et al., 2012, 2014), for NLRP3 (Nod-like receptor family, pyrin
domain containing 3) inflammasome activation. The yeast-to-hy-
pha transition is also required for IL-1b, pyroptosis, and PMN
recruitment that is associated with the transition from benign
colonization to symptomatic infection in vaginal candidiasis
(Peters et al., 2014a). Thus, as in orogastric candidiasis (Gross
et al., 2009; Hise et al., 2009), NLRP3 is likely activated in VVC
(Bruno et al., 2015). Indeed, NLRP3, in either the hematopoietic
or stromal compartments, and epithelial NLRC4 both played an
important role in immune resistance to oral candidiasis (Tomalka
et al., 2011).er Inc.
IL-22 is known to mediate anticandidal resistance at mucosal
surfaces under conditions of defective adaptive immunity
(Zelante et al., 2011), an activity to which the local microbiota
crucially contributes (Zelante et al., 2013). Sensing of tissue
damage via the NLRP3 or NLRP6 increased the ratio of IL-22/
IL-22 binding proteins (IL-22BP) via an IL-18-dependent down-
regulation of IL-22BP, thereby linking the activity of IL-22 to in-
flammasome activation (Huber et al., 2012). Whether, however,
IL-22 exerts a control over inflammasome activity is not known.
In the current study, we evaluated the role of IL-1 signaling, the
relative contribution of different inflammasomes, and the regula-
tion by IL-22 in murine and human VVC. We found that NLRP3
activation contributed to neutrophil recruitment and inflamma-
tion in infection, an activity counteracted by IL-22. Mechanisti-
cally, IL-22 promoted the activity of NLRC4 on epithelial cells,
resulting in the sustained production of the IL-1 receptor antag-
onist, IL-1Ra, capable of restraining NLRP3 activation. Symp-
tomatic infection in mice and humans occurred in conditions of
IL-1Ra deficiency and rescued in mice by replacement therapy
with the IL-1Ra anakinra. These results indicate that pathogenic
inflammasome activity in vaginal candidiasis is negatively regu-
lated by the IL-22/NLRC4/IL-1Ra axis and offer insights in the
pathogenesis and therapy of vaginal candidiasis.
RESULTS
Inflammasome Activity in Vaginal Candidiasis
To evaluate inflammasome activity in murine VVC, we intravagi-
nally infected C57BL/6 mice with Candida blastospores and
measured caspase 1 cleavage; lactate dehydrogenase (LDH) ac-
tivity; and IL-1b, IL-1a, and IL-18 production during infection.
Despite the ability of these mice to eventually control infection
and inflammation, fungi and PMN infiltrating the vaginal paren-
chyma with signs of epithelial damage at the early stages of
the infection have been described (De Luca et al., 2013). We
found here that the levels of the cleaved fragment of procas-
pase-1 (Figure 1A) and LDH (Figure 1B) increased during the first
week of the infection, and steadily declined thereafter to reach
control levels at 3–4 weeks after the infection. All the cytokines
were detected at the protein (in the vaginal fluids, VFs) and
mRNA (in vaginal tissue) levels during infection, with IL-1b and,
even more, IL-1a being maximally produced through the first
2 weeks of the infection. IL-18, in contrast, showed a bimodal
peak production, being observed early but also late in infection
(Figures 1C and D). Blocking IL-1b, more than IL-1a or IL-18,
by means of neutralizing antibody (see Figure S1A available
online) greatly reduced PMN recruitment, as revealed by vaginal
histopathology (Figure S1B) and vaginal expression of Mpo,
S100a8, and S100a9mRNA (Figure S1C). These results indicate
that inflammasome activity is present in mice with symptomatic
candidiasis and contributes to PMN recruitment.
NLRP3 and NLRC4 Are Nonredundantly Activated in
Vaginal Candidiasis
Wenext assessedwhether and whichmembers of the inflamma-
some family are activated during VVC. To this purpose, we
measured protein and gene expression of NLRP3 and NLRC4,
for their involvement in mucosal candidiasis (Tomalka et al.,
2011). As revealed by immunofluorescence and immunohisto-Cell Hoschemistry staining of vaginal tissues, NLRP3 expression was
robust during the first week of the infection on cells of the kerati-
nized epithelium (EC) as well as on recruited PMNs, to decline
thereafter (Figure 1E, and magnified in the insets). The expres-
sion of NLRC4 persistently increased during infection andmostly
on EC (Figure 1E). However, as phosphorylation on Ser 533 is
required for NLRC4 activity (Qu et al., 2012), we did immuno-
staining with a specific anti-phospho-(p)NLRC4 antibody to
reveal that pNLRC4 expression also increased in infection and
paralleled that of NLRC4. Gene (Figure 1F) and protein (Fig-
ure 1G) expression analysis by RT-PCR and western blotting,
respectively, confirmed that NLRP3 was maximally expressed
early in infection, whereas pNLRC4 activation occurred early
but, even more, 2 weeks later. These results indicate that multi-
ple inflammasomes are activated in infection and, interestingly,
that NLRC4 activation and NLRP3 inhibition are temporally
coincident.
NLRP3 Contributes to Pathogenic Inflammation in VVC
in the Absence of NLRC4
To unravel the functional activity of either NLRP3 or NLRC4
in VVC, we assessed Nlrp3–/– or Nlrc4–/– mice for susceptibility
to infection and inflammasome activity. Nlrp3–/– mice, although
not clearing the infection as efficiently as wild-type (WT) mice
(Figure 2A), had lower PMN (Figure 2B) and less vaginal immuno-
pathology (Figure 2C) than WT mice. Caspase-1 activation (Fig-
ure 2D), LDH activity (Figure 2E), and IL-1b production (Figure 2F)
were similarly lower in Nlrp3–/– than WT mice. Accordingly, the
levels of IL-17A and IL-17F (Figure 2G) were lower in Nlrp3–/–
than Nlrc4–/– mice.
Of great interest, immunofluorescence staining (Figure 2C)
and western blotting analysis (Figure 2H) of Nlrp3–/– vagina,
while negative for NLRP3 expression, showed an exuberant
pNLRC4 expression. These data suggest that NLRP3, more
than NLRC4, may contribute to caspase-1 activation, PMN infil-
tration, and inflammatory damage in VVC. The unexpected resis-
tance of Nlrp3–/– mice to vaginal immunopathology, along with
the remarkable expression of pNLRC4, would suggest that
NLRC4 could be involved as an alternative upstream sensor
that limits inflammation. The results in Nlrc4–/– mice showed
that this is indeed the case, as these mice, while controlling the
fungal growth as efficiently as WT mice (Figure 2A), showed a
massive infiltration ofPMN (Figure 2B), vaginal immunopathology
(Figure 2C), inflammasome activation (Figures 2D–2G), and huge
NLRP3 expression (Figures 2C and H). Consistent with the find-
ings that inflammasomes contribute to antimicrobial peptide pro-
duction in oral candidiasis (Tomalka et al., 2011) and lipocalin 2
expression correlated with protection in VVC (Zelante et al.,
2013), we found an upregulated expression in infection of the
Mbd1-4 and Lcn2 (encoding for lipocalin 2) genes (Figure S2A)
that was either dependent (Mbd1,2,4) or independent (Mbd3)
from both NLRP3 and NLRC4 or strictly dependent on NLRC4
only (Lcn2). These results suggest that NLRP3 and NLRC4,
despite overlapping functions, may have a distinct role in murine
VVC.NLRP3activationonECandmyeloid cellsmaycontribute to
fungal clearance but also to inflammation in the relative absence
of NLRC4. As such, these findings are different from those
observed in oral candidiasis (Tomalka et al., 2011), in which
NLRC4 more than NLRP3 contributed to PMN recruitment.t & Microbe 18, 198–209, August 12, 2015 ª2015 Elsevier Inc. 199
Figure 1. Inflammasome Activity in Vaginal Candidiasis
C57BL/6 mice (n = 6) were intravaginally inoculated with 5 3 106 C. albicans blastoconidia.
(A) Caspase-1 activation by immunoblotting of vaginal lysates with specific antibodies. Normalization was performed by probing the membrane with mouse-
monoclonal anti-b-actin antibody.
(B) Pyropoptosis was quantified as LDH activity (% cytotoxicity).
(C and D) (C) Cytokine levels (pg/mg, cytokine/total proteins for each sample) and (D) cytokine gene expression (real-time RT-PCR) at different days
postinfection (dpi).
(legend continued on next page)
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However, further experiments in bone marrow chimera mice
confirmed that PMN recruitment (Figure 2I) and inflammation
(Figure 2J) were lower, and fungal burden higher (Figure 2K), in
Nlrp3–/–/ Nlrc4–/–mice than Nlrc4–/–/Nlrp3–/– mice. Moreover,
PMN recruitment and inflammation were similarly low, and the
fungal burden high, in the vaginas of WT or Nlrc4/ infected
mice upon NLRP3 inhibition by siRNA (Figure S3). Thus, confirm-
ing the distinct host immune defenses against oral and vaginal
candidiasis (Fidel, 2002), NLRP3 contributes to inflammatory
cell recruitment and inflammation in murine VVC, an activity
counteracted by the activation of NLRC4 on EC.
Further experiments in mice with a high or low inflamma-
some activity, such as Tir8–/– and Il1r1–/– mice, respectively,
demonstrated that NLRP3 activation contributes to vaginal pa-
thology. SIGIRR/TIR8—a member of the IL-1R family acting as
a negative regulator of TLR/IL-1R signaling—is required for
host resistance to fungal infections and functions to negatively
regulate IL-1b-dependent activation of inflammatory Th17 re-
sponses (Bozza et al., 2008). Tir8–/– mice were susceptible and
Il1r1–/– mice resistant to vaginal infection, as revealed by the
elevated and persistent fungal growth (Figures 3A and 3C),
PMN infiltration (Figures 3Band3C), tissuepathology (Figure 3C),
caspase-1activation (Figure3D), and IL-1bproduction (Figure3E)
in Tir8–/– as compared to Il1r1–/– mice. NLRP3 expression was
robust in Tir8–/– mice, while pNLRC4 expression occurred in
Il1r1–/– mice, as revealed by immunostaining (Figure 3C), gene
(Figure 3F), and protein (Figure 3G) expression.
IL-22 Activates Protective NLRC4 in Response to
Candida
In light of the above results, we searched for possible mecha-
nisms behind NLRC4 activation and its regulation of NLRP3
activity. Because signs of vaginal epithelial damage and inflam-
mation and robust PMN recruitment were present in the relative
absence of IL-22 (De Luca et al., 2013; Yano et al., 2012), we hy-
pothesized that phosphorylation of NLRC4 could represent a
mechanism through which IL-22 may provide antifungal resis-
tance with limited pathology in infection. To this purpose, we as-
sessed parameters of inflammasome activity as well as NLRP3
or pNLRC4 expression in intravaginally infected Il22–/– mice.
Similar to C57BL/6 mice, IL-1b production (Figure 4A) and cas-
pase-1 cleavage (Figure 4B) were activated in Il22–/– mice.
However, NLRP3, but not pNLRC4, was activated in infection,
as revealed by vaginal expression of either inflammasome (see
Figures 4C and 4D and Figure 1 for comparison). This suggests
that NLRC4 failed to be phosphorylated in the absence of IL-22.
NLRC4 is activated upon phosphorylation at Ser533 by protein
kinase C d (PKCd) (Qu et al., 2012), a member of the serine/thre-
onine protein kinases family considered key signaling mediators
in the process of inflammation (Reyland, 2009). PKCd also phos-
horylates STAT3 (Litherland et al., 2010), a transcription factor(E) Periodic acid-Schiff-staining, immunohistochemistry (scale bars, 100 mm), a
antibodies to NLRP3, NLRC4, and p (phospho) NLRC4. Sections were stained
biotinylated or fluorescent antibodies. Images were acquired with a 403 objecti
Diamino-2-phenylindole was used to counterstain tissues and to detect nuclei.
(F and G) (F) Gene and (G) protein analysis (RT-PCR and western blotting, resp
(histology/immunostaining/western blotting) from four independent experiments.
also Figure S1.
Cell Hosregarded as the principal and dominant mechanism of cellular
activation by IL-22 (De Luca et al., 2010). We therefore assessed
whether IL-22 would be able to phosphorylate NLRC4 via
PKCd by exposing vaginal cultures to different stimuli, including
flagellin, a known activator of the neuronal apoptosis inhibitor
protein (NAIP)5–NLRC4 pathway (Zhao et al., 2011) in the pres-
ence of IL-22.We found that flagellin (Figure 4E) and liveCandida
cells + LPS, but not LPS or Candida alone (Figure 4F), activated
PKCd. IL-22 greatly increased PKCd activation in response to
flagellin, an activity counteracted by the PKCd inhibitor rottlerin
(Figure 4E), and activated PKCd in response to Candida + LPS
and, of great interest, to Candida alone (Figure 4F). IL-22 also
induced STAT3 phosphorylation (data not shown) and the
expression of Nos2 (Figure 4G), which is known to be positively
regulated by PKCd (Leppa¨nen et al., 2013). Of interest, IL-22 also
increased IL-1Ra in vaginal cultures, irrespective of NLRP3 (Fig-
ure 4H). These data suggest that IL-22 is required for NLRC4
phosphorylation in response to Candida via PKCd. Confirming
the upstream role for IL-22/PKCd in NLRC4 activation, IL-22
administration in vivo upregulated pNLRC4 and Lcn2 expression
and decreased cytotoxic damage in the vaginas of infectedmice
(Figure 4I). In contrast, treatment with rottlerin, known to mimic
PKCd inhibition (Soltoff, 2007), while inhibiting PKCd (Figure 4J),
decreased pNLRC4 expression and increased NLRP3-associ-
ated inflammation (Figure 4K) and PMN recruitment (Figure 4L).
Rottlerin was ineffective in Il22–/– mice (data not shown), a finding
indicating that IL-22 is required for PKCd activation in infection.
Therefore, in vitro and in vivo evidence point to a functional
role of the IL-22/PKCd axis in NLRC4 activation in murine VVC.
Further confirming this, the aryl hydrocarbon receptor/IL-22
axis was much upregulated in conditions of high pNLRC4
expression, such as in Nlrp3–/– mice (from 27 ± 5 to 69 ±
7 pg/ml IL-22 levels in the vagina of C57/BL6 versus Nlrp3–/–
mice, at 3 dpi).
NLRC4 Dampens Pathogenic NLRP3 Activity via IL-1Ra
IL-1Ra is a potent suppressor of inflammasome activity (Petrasek
et al., 2012). Although most intracellular IL-1Ra remains in the
cytoplasm of cells, some isoforms may be released from EC in
someconditionsandmay functionasextracellular receptor antag-
onists of IL-1RI (Levine et al., 1997). We measured IL-1Ra pro-
duction in vivo during infection and found a dichotomous pattern
of production that correlates with levels of immunopathology in
mice with vaginal candidiasis. It was increasingly produced in
more resistant WT, Nlrp3–/–, and Il1r1–/– mice, reaching a peak
level at around 2 weeks, but only produced early in infection with
a sharpdecline thereafter in conditionsof inflammatory pathology,
suchas inTir8–/–,Nlrc4–/–, and Il22–/–mice (Figure5A). Thus, a sus-
tained IL-1Ra production appears to be required for successful
control of inflammation during infection, an activity for which IL-
22 and NLRC4 are required. Experiments carried out in Il1ra–/–nd immunofluorescence staining (scale bars, 25 mm) of vaginal sections with
with the relevant primary antibody overnight at 4C followed by secondary
ve and the analySIS image processing software. Insets, 1003 objective. 40-6-
ectively) on ex vivo vaginas. Data (mean ± SD) are pooled or representative
*p < 0.05, **p < 0.01, ***p < 0.001, infected versus uninfected (dpi 0) mice. See
t & Microbe 18, 198–209, August 12, 2015 ª2015 Elsevier Inc. 201
Figure 2. NLRP3 and NLRC4 Have Distinct
Roles in VVC
(A) Nlrp3–/– or Nlrc4–/– mice (n = 6) were intra-
vaginally inoculated with 5 3 106 C. albicans
blastoconidia and assessed for vaginal fungal
burden (Log10 CFU/100ml VF ± SD).
(B) PMN recruitment in VF (identified by nuclear
morphology and enumerated per field at 1003
magnification).
(C) Vaginal pathology (periodic acid-Schiff-
staining of sections; scale bars, 100 mm) and
immunofluorescence staining with anti-NLRP3 or
anti-pNLRC4 antibodies (scale bars, 25 mm).
Sections were stained with the relevant primary
antibody overnight at 4C followed by secondary
FITC or TRITC antibody. Images were acquired
using a fluorescence microscope with a 403
objective and the analySIS image processing
software. 40-6-Diamino-2-phenylindole was used
to counterstain tissues and to detect nuclei.
(D) Caspase-1 activation, by immunoblotting of
vaginal lysates with specific antibodies.
(E) LDH activity (% cytotoxicity).
(F and G) (F) IL-1b, (G) IL-17A, and IL-17F (pg/mg,
cytokine/total proteins for each sample) in VF.
(H) NLRP3 and pNLRC4 protein expression
(western blotting) on ex vivo vaginas from Nlrp3–/–
or Nlrc4–/– mice. Note the negative expression
of NLRP3 and pNLRC4 inNlrp3–/– or Nlrc4–/– mice,
respectively). Results represent mean cytokine
levels from samples pooled from three experi-
ments (n = 4–6 total samples per group).
(I–K) (I) PMNs quantification (by nuclear
morphology) in VF, (J) vaginal pathology (periodic
acid-Schiff-staining of sections; scale bars,
100 mm; red arrows indicate fungi, and yellow ar-
rows indicate neutrophils), and (K) fungal burden in
bone marrow chimera mice after vaginal infection
with C. albicans. Data (mean ± SD) are pooled or
representative (histology/immunostaining/western
blotting) from four independent experiments.
*p < 0.05, chimeric Nlrp3–/– or Nlrc4–/– mice versus
C57BL/6/C57BL/6 mice. See also Figures S2
and S3.mice confirmed the protective role of IL-1Ra in infection. Signs
of an exaggerated inflammatory response (Figure 5B), likely ac-
counting for the restrained fungal growth (Figure 5C), huge PMN
recruitment even before the infection (Figure 5D), caspase-1
cleavage (Figure 5E), and LDH release (Figure 5F), were all
observed in Il1ra–/– mice along with a robust NLRP3, but not
pNLRC4, expression (Figure 5G). Of great interest, treatment
with anakinra decreased the fungal growth (Figure 5C), PMN
recruitment (Figure 5D), vaginal inflammation (Figure 5B), and tis-
sue damage (Figure 5F) in bothWTand Il1ra–/–mice. These results
point to a possible protective role of IL-1Ra in murine VVC, such
that exogenous supply of anakinra could be of therapeutic value.202 Cell Host & Microbe 18, 198–209, August 12, 2015 ª2015 Elsevier Inc.IL-22 Activates NLRC4 in Response
to Candida in Human Vaginal Cells
Based on these findings, and to recapitu-
late the murine data, we assessed NLRP3
and pNLRC4 expression in the human
HeLa cell line exposed to germinatedCandida cells in the presence of IL-22 and/or PCKd inhibition
by siRNA and measured levels of IL-1b, IL-1Ra, and IL-22 in hu-
man RVVC. Confirming the murine findings, pNLRC4, but not
NLRP3, expression was increased by IL-22 in response to
Candida or flagellin used as a positive control (Figure 6A), in a
PKCd-dependent manner. In fact, IL-22 activated PKCd in
response to Candida (Figures 6B and 6C) and PKCd inhibition
prevented the activation of NLRC4 (Figure 6D). Similar results
were obtained with the vulvovaginal A431cells (Figure S4). In
terms of cytokine profile, high levels of IL-1b and low levels of
IL-1Ra and IL-22 were observed in the VF of patients with
RVVC (Figure 6E). Altogether, these data provide evidence that
Figure 3. NLRP3 Contributes to Pathogenic
Inflammation in VVC
(A) Tir8–/– or Il1r1–/– mice (n = 6) were intravaginally
inoculated with 5 3 106 C. albicans blastoconidia
and assessed for vaginal fungal burden (Log10
CFU/100ml VF ± SD).
(B) PMNs quantification (by nuclear morphology)
in VF.
(C) Vaginal pathology (periodic acid-Schiff-stain-
ing of sections; scale bars, 100 mm) and immuno-
fluorescence staining with NLRP3 and pNLRC4
antibodies (scale bars, 25 mm). Sections were
stained with the relevant primary antibody over-
night at 4C followed by secondary FITC or TRITC
antibody. Images were acquired using a fluores-
cence microscope with a 403 objective and the
analySIS image processing software. 40-6-Dia-
mino-2-phenylindole was used to counterstain
and to detect nuclei.
(D) Caspase-1 activation by immunoblotting of
vaginal lysates with anti-murine antibodies.
(E) IL-1b levels (pg/mg, cytokine/total proteins for
each sample, mean ± SD) in the vaginal fluids.
(F and G) (F) Gene and (G) protein expression
analysis (RT-PCR and western blotting, respec-
tively) on ex vivo vaginas. Data (mean ± SD) are
pooled or representative (histology/immunostain-
ing/western blotting) from four independent ex-
periments. *p < 0.05, **p < 0.01, Tir8–/– or Il1r1–/–
mice versus WT mice.NLRP3 and NLRC4 are likely activated in the human infection
where a defective production of IL-1Ra and IL-22 may be a
risk factor for RVVC.
DISCUSSION
The present study shows that NLRP3 and NLRC4 are activated
in vaginal candidiasis, play a non redundant role in infection,
and are orchestrated by IL-22. Our results confirm previous ob-
servations obtained in the orogastric model of infection in which
NLRP3 was required to prevent the systemic dissemination of
mucosal infection while NLRC4 was locally protective (Tomalka
et al., 2011). At variance with that study, we found that NLRP3,
more than NLRC4, contributed to PMN recruitment in infection,
a finding confirming major tissue-specific differences in innate
immune antifungal pathways (Bruno et al., 2015; Fidel, 2002).
Similar to that study, we found that functional NLRC4 activity
in ECs is required for protection tomucosal candidiasis. The pro-
tective action of NLRC4 in intestinal infections (Franchi et al.,
2012; Nordlander et al., 2014) is mostly carried out in coopera-
tion, if not redundantly (Broz et al., 2010), with NLRP3 (Broz
et al., 2010; Man et al., 2014) to drive robust IL-1b signaling
(Broz et al., 2010; Man et al., 2014). We instead found that either
inflammasome plays a distinct role in vaginal infection. Via
caspase-1 cleavage and IL-1b production, NLRP3 activation
contributed to neutrophil recruitment and inflammation in infec-
tion, a finding suggesting that regulation of NLRP3 activity is
required for the proper control of the inflammatory pathology
associated with mucosal Candida infections. Indeed, we found
that NLRP3-dependent PMN infiltration and inflammation wereCell Hosassociated with disease severity in conditions of unrestrained
NLRP3 activity, such as those observed in highly susceptible
Tir8–/–, Il1ra–/–, or Nlrc4–/– mice. Of interest, despite experiencing
a similar degree of inflammatory pathology, the fungal growth
was different in these mice, a finding suggesting the contribution
of receptors other than inflammasomes in restraining the fungal
growth. In contrast, despite an initial high fungal burden, disease
severity was minimal in Il1r1–/– mice and correlated with defec-
tive NLRP3 activity. Thus, the limited inflammatory pathology
observed in Il1r1–/– mice not only recapitulates what has been
already observed in gastrointestinal candidiasis (Bellocchio
et al., 2004; Bozza et al., 2008) but also points to the existence
of a thigh control of NLRP3 activity upon the exposure to the fun-
gus. While it is conceivable that the net functional activity of
NLRP3 in infection is also contingent upon the fungal load, we
have found that NLRC4 fine-tunes NLRP3 activity in candidiasis.
NLRC4 has been implicated in a proinflammatory defense
mechanism in the intestine against foreign, but not commensal,
bacteria (Franchi et al., 2012; Nordlander et al., 2014). It has also
been proposed that NLRC4 activation can be detrimental after
antibiotic treatment that severely alters the composition of mi-
crobiota (Ayres et al., 2012). We showed here that Nlrc4–/–
mice developed a severe disease and inflammatory response
that was concomitant with NLRP3 activation, which suggests
that, in addition to defensin production, NLRC4 acts as a nega-
tive regulator of NLRP3 activity. The IL-1/NRLP3 pathway is
tightly controlled via a number of positive and negative regula-
tors (Latz et al., 2013). In response to Candida, type I interferon
via STAT1 or IL-10 via STAT3 inhibited NALP3 activity (Guarda
et al., 2011). We found that IL-1Ra, a potent suppressor oft & Microbe 18, 198–209, August 12, 2015 ª2015 Elsevier Inc. 203
Figure 4. IL-22 Activates Epithelial NLRC4 in Response to Candida
Il22–/– mice (n = 6) were intravaginally inoculated with 5 3 106 C. albicans blastoconidia.
(A) IL-1b levels (pg/mg, cytokine/total proteins for each sample) in VF.
(B) Caspase-1 activation by immunoblotting of vaginal lysates with anti-murine antibodies.
(C) Vaginal pathology (periodic acid-Schiff-staining of sections; scale bars, 100 mm) and immunofluorescence staining with NLRP3 and pNLRC4 antibodies
followed by secondary FITC or TRITC antibody (scale bars, 25 mm).
(D) Western blotting of NLRP3 and pNLRC4 on ex vivo vaginas.
(E and F) PKCd activation (immunoblotting with anti-PKC delta [phospho T505] antibody) in ex vivo vaginal cultures exposed to flagellin (E) or LPS, live germinated
Candida (CA) cells (F) in the presence of IL-22 for 4 hr and/or the PKCd inhibitor rottlerin. Untreated, flagellin only.
(G) Nos2 expression (RT-PCR) in vaginal cells.
(H) IL-1Ra levels (pg/mg, cytokine/total proteins, mean ± SD) in vaginal culture supernatants.
(I) NLRP3 and pNLRC4 expression (immunofluorescence staining), Lcn2 expression (RT-PCR), and LDH activity (% cytotoxicity) (7 dpi) in the vaginas of infected
C57BL/6 mice intravaginally treated with IL-22. Control mice received PBS. *p < 0.05, Il22–/– mice versus WT mice, and treated versus untreated.
(J–L) (J) Immunoblotting of PKCd in vaginal lysates, (K) vaginal pathology (periodic acid-Schiff-staining of sections; scale bars, 100 mm), and immunofluorescence
staining with NLRP3 and pNLRC4 antibodies (scale bars, 25 mm) and (L) PMNs quantification (by nuclear morphology) in VF of infectedmice treated with rottlerin.
Control mice received PBS. Data (mean ± SD) are pooled or representative (histology/immunostaining/western blotting) from three independent experiments.
*p < 0.05, treated versus untreated mice.inflammasome activity (Petrasek et al., 2012), also blocked
NLRP3 in response to the fungus. Although typically secreted
by monocytes and PMN, bioactive IL-1Ra isoforms could be
released from EC in some conditions andmay represent amech-
anism bywhich IL-1 bioactivity is locally modulated (Levine et al.,
1997).204 Cell Host & Microbe 18, 198–209, August 12, 2015 ª2015 ElseviAccordingly, EC expressing NLRC4 likely contributed to the
sustained production of IL-1Ra that discriminates between resis-
tance and susceptibility to the infection. Somehow unexpected,
NLRP3 was apparently unable to contribute to sustained IL-1Ra
production. In search for a plausible explanation for this phe-
nomenon, the fact that caspase-1 is able to cleave the TRIFer Inc.
Figure 5. NLRC4 Dampens Pathogenic
NLRP3 Activity via IL-1Ra
(A) IL-1Ra levels (pg/mg, cytokine/total proteins for
each sample) in the VF of mice (n = 6) intravaginally
infected with 5 3 106 C. albicans blastoconidia.
Results represent mean cytokine levels (±SD) from
samples pooled from three experiments (n = 4–6
total samples per group).
(B) Vaginal pathology (periodic acid-Schiff-stain-
ing of sections; scale bars, 100 mm).
(C–G) (C) Vaginal fungal burden (Log10 CFU/100ml
VF ± SD), (D) PMN recruitment in VF (identified by
nuclear morphology and enumerated per field at
1003 magnification), (E) caspase-1 activation by
immunoblotting, (F) LDH activity (% cytotoxicity),
and (G) immunofluorescence staining of vaginas
with NLRP3 and pNLRC4 antibodies (scale bars,
25 mm) in Il1ra–/– mice (n = 6) intravaginally inocu-
lated with 5 3 106 C. albicans blastoconidia and
treated with 10 mg/kg anakinra intraperitoneally
daily for 7 days, starting the day of the infection.
Assays were done at 7 dpi. Data (mean ± SD) are
pooled or representative (histology/immunostain-
ing/western blotting) from three independent
experiments. *p < 0.05, **p < 0.01, ***p < 0.001,
Nlrp3–/–, Il1r1–/–, Il22–/–, Nlrc4–/–, and Tir8–/– mice
versus WT mice and treated versus untreated.adaptor, thus limiting TRIF signaling, could be a possible expla-
nation (Jabir et al., 2014). Indeed, TRIF signaling was required
not only to eventually restrain the inflammatory response in
VVC (De Luca et al., 2013) but also to sustain IL-1Ra production
in infection (unpublished data). This may explain the relative loss
of IL-1Ra in conditions of sustained caspase-1 activation,
such as that occurring downstream NRLP3, and less, NLRC4
signaling. Therefore, NLRC4 contributes to sustained production
of IL-1Ra to restrain pathogenic inflammasome activation in
infection.
NLRC4 is specifically activated by a functional bacterial type
III or IV secretion system (T3SS/T4SS) or flagellin (Miao et al.,
2010; Zhao et al., 2011). Ligands are believed to directly bind
distinct members of the NAIP NLR subfamily to subsequently
activate the NLRC4 inflammasome (Kofoed and Vance, 2011).
Evidence shows that NLRC4 is activated upon phosphorylation
at Ser533 by PKCd (Qu et al., 2012), a known regulator of
inflammation via the iNOS pathway (Leppa¨nen et al., 2013).
PKCd is a ubiquitously expressed isoform of PKC that is sub-
ject to phosphorylation on tyrosine residues by a variety of
stimuli, particularly after activation of cells by growth factor
receptors (Denning et al., 1996). Germinated Candida cells,
known to activate NLRP3 (Gross et al., 2009; Hise et al.,
2009), were unable to activate NLRC4 phosphorylation on
ex vivo vaginas and on vaginal human ECs. However, they
did so in the presence of IL-22. It is of interest that PKCd con-
tributes to skin homeostasis (Koppel et al., 2014) and also
phoshorylates STAT3 (Litherland et al., 2010), a transcription
factor regarded as the dominant mechanism of cellular activa-
tion by IL-22 (De Luca et al., 2010). Thus, similar to other mi-
crobes (Taxman et al., 2010), Candida has devised a strategy
to manipulate the inflammasome function and downstream
signaling to avoid inflammation with the complicity of IL-22.
This implies that IL-22, known to mediate early anticandidalCell Hosresistance at mucosal surfaces (Zelante et al., 2011), also func-
tions as a danger signal capable of activating epithelial NLRC4
to restrain inflammation to the benefit of the host but also of the
fungus, given that inflammation promotes fungal virulence (Ze-
lante et al., 2012). It is quite likely that IL-18, via downregulation
of IL-22BP (Huber et al., 2012), may influence the temporal ac-
tivity of IL-22 in infection, thus offering a plausible explanation
for the temporally coincident IL-18 production and NLRC4
activation.
Overall, the data of the present study further add to the biolog-
ical functions of IL-22 in C. albicans infection that include a
previously undescribed control over pathogenic inflammasome
activation via the PKCd/NLRC4/IL-1Ra axis (Figure 7). Given
the ability of IL-22 to regulate IL-1Ra production, our findings
may explain why genetic deficiency of IL-22 (De Luca et al.,
2013) contributes to the low IL-1Ra activity in RVVC. As such,
these findings may offer insights in the pathogenesis and
therapy of vaginal candidiasis. Not only could the IL-1b and IL-
1Ra levels be used as a biomarker of disease susceptibility,
but anakinra may prove to be a therapeutic agent in RVVC. In
contrast to anti-TNF approaches, whose utility was compro-
mised by infectious complications, administration of IL-1Ra
has demonstrated an excellent safety profile, and its use has
not been associated with adverse reactions or superinfections
with long-term treatment (Dinarello et al., 2012). Our study
shows that the elucidation of pathogenetic mechanisms at the
molecular level may lead to the development of approaches to-
ward controlling inflammasome-dependent inflammatory and
infectious processes.EXPERIMENTAL PROCEDURES
Detailed experimental procedures can be found in the Supplemental Experi-
mental Procedures.t & Microbe 18, 198–209, August 12, 2015 ª2015 Elsevier Inc. 205
Figure 6. IL-22 Activates NLRC4 in
Response to Candida in Human Vaginal
Cells
(A) HeLa cells were exposed to live germinated
C. albicans cells (magnified in the insets), flagellin
(Flag), or nigericin + LPS (Nig) in the presence or
not of human recombinant IL-22 and assessed for
immunofluorescence staining with anti-NLRP3 or
anti-pNLRC4 antibodies.
(B–D) (B and C) PKCd activation (immunoblotting
with anti-PKC delta [phospho-T505] antibody) and
(D) pNLRC4 expression (immunoblotting with anti-
pNLRC4 antibody) of cells treated as above and
silenced for PKCd.
(E) Cytokine (pg/mg, cytokine/total protein) pro-
duction in the vaginal fluids of healthy women or
patients with RVVC. Phalloidine staining highlights
the NLRP3 cytoplasmic localization. **p < 0.01;
*p < 0.05, controls versus RVVC. See also
Figure S4.Ethics Statement
Murine experiments were performed according to the Italian Approved Ani-
mal Welfare Authorization 360/2015-PR and Legislative Decree 26/2014
regarding the animal license obtained by the Italian Ministry of Health lasting
for five years (2015-2020). The human study approval was provided by the
University Ethics Committee of Perugia (Prot. 2012-028), and informed
written consent was obtained from all participants for genetic and functional
assessments.
Patients and Control Subjects
The study population included Caucasian women recruited at the S. Maria
della Misericordia Medical Center (Perugia, Italy), Wayne State University
School of Medicine (Detroit, MI, USA), and Radboud University Nijmegen
Medical Center (Nijmegen, The Netherlands) and diagnosed with at least
three documented episodes of VVC in a year; control subjects consisted of
age-matched healthy Caucasian women with no gynecologic complaints, no
history of vaginal Candida infection, and who were currently culture negative
for vaginal pathogens (De Luca et al., 2013).
Mice
Female C57BL/6, 8–10 weeks of age, were purchased from Charles River
(Calco, Italy). Homozygous Nlrp3–/–, Nlrc4–/–, Trif–/–, Il1r1a–/–, and Il22–/– mice
on the C57BL/6 background were bred under specific pathogen-free condi-
tions at the Animal Facility of the University of Perugia, Perugia, Italy. Tir8–/–
and Il1r1–/–mice were bred under specific pathogen-free conditions at the An-
imal Facility at the Humanitas Hospital, Milan, Italy.
Fungal Strains, Vaginal Infection, and Treatments
Estrogen-treated mice were inoculated intravaginally with 5 3 106 viable
C. albicans 3153A blastospores from early-stationary-phase cultures. CFUs
were enumerated after incubation of Sabouraud-dextrose agar plates at
36C for 24 hr and expressed as log10 CFU/100 ml of lavage fluid. Cytospin206 Cell Host & Microbe 18, 198–209, August 12, 2015 ª2015 Elsevier Inc.preparations of the lavage fluids were stained
withMay-Gru¨nwald-Giemsa. For histology, the va-
ginas sections were stained with periodic acid-
Schiff reagent. The BX51 microscope equipped
with a high-resolution DP71 camera (Olympus)
was used. Mice received 10 mg of cytokine neutral-
izing antibodies intravaginally from the day of the
infection until the end of the experiment; 1 mg of
recombinant IL-22 intravaginally, the day of the
infection and 1 and 2 days after; 10 mg/kg of ana-
kinra intraperitoneally, daily for 7 days, starting the
day of the infection; and 10 mg of rottlerin intrava-ginally, the day before, the day of the infection, and 1 day later. Control mice
received PBS.
SiRNA
Cells were transfected with 25 nM siRNA or equivalent doses of nonspecific
control siRNA using Lipofectamine 3000 Reagent (Life technologies). Mice
received 10 mg/kg of siRNA intravaginally, the day before infection, and 1
and 2 days after infection.
Generation of Chimera Mice
Lethally irradiated mice (exposed to a Cesium-139 c-radiation source for a to-
tal full body dose of 700 rads) received 63 106 bone marrow cells from pooled
donor mice via tail vein injection and allowed to recover for 4 weeks.
Pyropoptosis
Pyropoptosis was assessed by LDH Cytotoxicity Assay Kit (Abcam).
Cell Cultures
HeLa, A431 human cells, and vaginas from untreated mice were exposed to
10 mg/ml LPS (1 hr pretreatment) + 5 mM nigericin, 5 mg/ml flagellin, 10 mM rot-
tlerin (1 hr pretreatment) or germinated live C. albicans (cells:fungi ratio of 1:1),
in the presence of 20 ng/ml of IL-22 for 4 hr before assays.
Immunofluorescence and Immunohistochemistry Staining
Vaginal sections and human cells were stained overnight at 4Cwith anti-Nlrp3
(Abcam) or anti-Nlrc4 (Millipore) antibodies followed by secondary TRITC an-
tibodies. Anti-Nlrc4-P (Genentech) followed by anti-hamster FITC (Sigma) was
used for pNLRC4. For immunohistochemistry, sections were incubated over-
night with polyclonal anti-Ipaf (NLRC4) (Millipore, Darmstadt, Germany) or
anti-CIAS1/NALP3 antibody (Abcam, Cambridge, UK), followed by the sec-
ondary biotinylated antibodies. In order to highlight the NLRP3 cytoplasmic
localization, cells were also stained with phalloidine (Alexa Fluor 488 dye).
Figure 7. Proposed Model for the Role of the IL-22/NLRC4/IL-1Ra
Axis in Mucosal Candidiasis
Activation of NLRP3 in response to the fungus and/or DAMPs contributes to
neutrophil recruitment and inflammation, an activity that is restrained by IL-22.
Produced via AhR, IL-22 activates NLRC4 on epithelial cells via PKCd phos-
phorylation, which results, among other functions, in a sustained production of
the IL-1 receptor antagonist, IL-1Ra, that restrains NLRP3 activity. Thus, the
IL-22/NLRC4/IL-1Ra axis may restrain pathogenic inflammasome activity to
the fungus at mucosal surfaces, thus offering insights into molecular mecha-
nisms regulating commensalism and infectivity by the fungus. AhR, aryl hy-
drocarbon receptor.40-6-diamino-2-phenylindole (DAPI,Molecular Probes)wasused tocounterstain
cells and to detect nuclei. Images were acquired using a microscope (BX51
Olympus) with a 403 objective and the analySIS image processing software.
Western Blotting
Blots of cell lysates were incubated with rabbit anti-murine Caspase-1 p10
(Santa Cruz Biotechnology), goat polyclonal anti-Nlrp3 (Sigma), anti-Nlrc4
(Millipore), anti-Nlrc4-P (Genentech), and rabbit polyclonal anti-PKC delta
(phospho-T505) antibodies (Abcam) followed by horseradish peroxidase-con-
jugated secondary IgG. Images were acquired with LiteAblotPlus chemilumi-
nescence substrate (Euroclone S.p.A.), using ChemiDoc XRS and Imaging
system (Bio-Rad Laboratories).
ELISA and Real-Time PCR
The levels of murine and human cytokines and chemokines were determined
by Kit ELISA (eBioscience Kit ELISA and R&D Systems). Data were normalizedCell Hosto total protein levels for each sample as determined using the Bio-Rad Protein
assay (Life Science, Bio-Rad Laboratories S.r.l. Milan Italy) and expressed as
pg cytokine/mg total protein. Results represent mean cytokine levels (±SD)
from samples pooled from two similar experiments (n = 3–4 total samples
per group). Real-time PCR was performed using the iCycler iQ detection sys-
tem (Bio-Rad) and SYBR Green chemistry (Finnzymes Oy) on total RNA ex-
tracted using RNeasy Mini Kit (QIAGEN, Milan, Italy) and reverse transcribed
with Sensiscript Reverse Transcriptase (QIAGEN). The PCR primers were as
described (De Luca et al., 2010). Amplification efficiencies were validated
and normalized against Gapdh. The mRNA-normalized data were expressed
as relative mRNA in knockout versus WTmice and infected versus naive mice.
Statistical Analysis
Student’s t test or analysis of variance (ANOVA) with Bonferroni’s adjustment
was used to determine statistical significance (p < 0.05). The data reported
are either from one representative experiment out of three to five independent
experiments (western blotting and RT-PCR) or otherwise pooled from three to
five experiments. The in vivo groups consisted of 6–8 mice/group. Data were
analyzed by GraphPad Prism 4.03 program (GraphPad Software). Genotype
distributions among controls and VVC and RVVC patients were analyzed by
Fisher’s exact test.
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